

[ Fri, May 03rd 2019
] - WOPRAI
[ Fri, May 03rd 2019
] - WOPRAI
[ Fri, May 03rd 2019
] - WOPRAI
[ Fri, May 03rd 2019
] - WOPRAI
[ Fri, May 03rd 2019
] - WOPRAI
[ Fri, May 03rd 2019
] - WOPRAI

[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
[ Thu, May 02nd 2019
] - WOPRAI
Liana Moussatos Maintained (UTHR) at Buy with Increased Target to $273 on, May 2nd, 2019
Liana Moussatos of Wedbush, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $269 to $273 on, May 2nd, 2019.
Liana has made no other calls on UTHR in the last 4 months.
There is 1 other peer that has a rating on UTHR. Out of the 1 peers that are also analyzing UTHR, 0 agree with Liana's Rating of Hold.
This is the rating of the analyst that currently disagrees with Liana
- Geoff Meacham of "Barclays" Maintained at Sell with Decreased Target to $95 on, Friday, March 1st, 2019